1,2-Dichloroethane → N-[5-chloro-2-(1H-tetraazol-1-yl)benzyl]-1-[(1-tert-butoxycarbonyl-2-methylazetidin-2-yl)carbonyl]-L-prolinamide

HRID 857771Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 857771
C(Cl)CCl.C1C=NC2N(O)N=NC=2C=1.CN1CCOCC1.Cl.[Cl:23][C:24]1[CH:25]=[CH:26][C:27]([N:39]2[CH:43]=[N:42][N:41]=[N:40]2)=[C:28]([CH:38]=1)[CH2:29][NH:30][C:31](=[O:37])[C@@H:32]1[CH2:36][CH2:35][CH2:34][NH:33]1.[C:44]([O:48][C:49]([N:51]1[CH2:54][CH2:53][C:52]1([CH3:58])[C:55](O)=[O:56])=[O:50])([CH3:47])([CH3:46])[CH3:45]>CN(C=O)C>[Cl:23][C:24]1[CH:25]=[CH:26][C:27]([N:39]2[CH:43]=[N:42][N:41]=[N:40]2)=[C:28]([CH:38]=1)[CH2:29][NH:30][C:31](=[O:37])[C@@H:32]1[CH2:36][CH2:35][CH2:34][N:33]1[C:55]([C:52]1([CH3:58])[CH2:53][CH2:54][N:51]1[C:49]([O:48][C:44]([CH3:47])([CH3:46])[CH3:45])=[O:50])=[O:56]

Komponenten

7

Versuchsvorschrift

EDC (0.104 g, 0.54 mmol), HOAt (24.6 mg, 0.18 mmol), NMM (0.079 mL, 0.72 mmol), and N-[5-chloro-2-(1H-tetraazol-1-yl)benzyl]-L-prolinamide hydrochloride (Example 26, Step B, 0.143 g, 0.42 mmol) were added to a stirred solution of racemic 1-(tert-butoxycarbonyl)-2-methylazetidine-2-carboxylic acid (0.143 g, 0.36 mmol in DMF (1.1 mL). After 3 h at room temperature the reaction was partitioned between EtOAc and water. The organic layer was washed with brine, dried (Na2SO4) and concentrated in vacuo. The two diastereomers were separated and purified by reverse phase HPLC. The more polar diastereomer was concentrated in vacuo. N-[5-chloro-2-(1H-tetraazol-1-yl)benzyl]-1-[(1-tert-butoxycarbonyl-2-methylazetidin-2-yl)carbonyl]-L-prolinamide (diastereomer A) was obtained as a glass. MS m/z=404.6).

Aufarbeitung

  1. customAfter 3 h at room temperature the reaction was partitioned between EtOAc and water
  2. washThe organic layer was washed with brine
  3. dry with materialdried (Na2SO4)
  4. concentrationconcentrated in vacuo
  5. customThe two diastereomers were separated
  6. custompurified by reverse phase HPLC
  7. concentrationThe more polar diastereomer was concentrated in vacuo

Quellen und Nachweise

ORD-Eintrag
ord-8781b70d0e0f4e7eb12b04d282b9cb0c
Quelldatensatz
uspto-grants-2006_12
Patentnummer
US07144899B2

Notizen zur Reaktion

Wird geladen…